Form D · Biotechnology
UBIVAC, INC.
Portland, OR · CIK 0001713945
Offering snapshot reported Aug 27, 2026 · SEC filing
- Reported sold
- $80K Indefinite offering
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Aug 2, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 27, 2026 | Initial | $80,000 | No comparison | 2 | SEC filing |
| Mar 11, 2025 | Initial | $35,000 | No comparison | 2 | SEC filing |
| Sep 23, 2024 | Amendment | $150,000 | $100,000vs Jun 12, 2024 | 3 | SEC filing |
| Jun 12, 2024 | Initial | $50,000 | No comparison | 2 | SEC filing |
| Nov 8, 2023 | Initial | $100,000 | No comparison | 2 | SEC filing |
| Apr 15, 2022 | Initial | $250,000 | No comparison | 1 | SEC filing |
| Apr 29, 2019 | Amendment | $1,945,773 | $1,145,773vs May 25, 2018 | 10 | SEC filing |
| May 25, 2018 | Initial | $800,000 | No comparison | 1 | SEC filing |
| Aug 4, 2017 | Initial | $200,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-595536
Source: Form D, filed Aug 27, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Steve Buhaly | Executive |
| Bernard A. Fox, Iii | Executive |
| Bernard A. Fox Iii, Mba | Executive |
| Bernard A. Fox, Mba | Executive |
| Bernard A. Fox, Ph.D | Director, Executive |
| Bernard Fox, Ph.D. | Director, Executive |
| Hong Ming Hu, Ph.D | Director, Executive |
| Hong Ming Hu, Ph.D. | Director, Executive |
| Nancy Lime | Executive |
| Sung Poblete, R.N., Ph.D. | Director |
| Jon Wigginton, M.D. | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
18183 S.W. Boones Ferry Road
Portland, OR, 97224
Phone: 503-292-4066
Portland, OR, 97224
Phone: 503-292-4066